Principal Financial Group’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
AWA
Principal Financial Group's SOPH Position: Q2 2026 in Review
Principal Financial Group increased its SOPHiA GENETICS (SOPH) stake by 68% in Q2 2026, buying an estimated $4.85M and bringing the position to 2,364,256 shares worth $13.6M. The position accounts for 0.01% of the portfolio, ranked #1234.
Principal Financial Group first reported a position in SOPH in Q3 2021 and has held it in 20 quarters since. The position peaked at $14.4M in Q3 2021. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Principal Financial Group held 2,364,256 shares of SOPHiA GENETICS worth $13.6M as of Q2 2026.
- Principal Financial Group bought 955,014 SOPHiA GENETICS shares in Q2 2026, an estimated $4.85M.
- SOPHiA GENETICS made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #1234 holding.
- Principal Financial Group first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 20 quarters since.
- Principal Financial Group's SOPHiA GENETICS position peaked at $14.4M in Q3 2021.
- 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.